Rizatriptan 10 MG RPD in the Treatment of Acute Migraine

Summary

This is a multicentre, open label, prospective, randomized, two-attack study with active comparator in patients reporting inadequate response to analgesics and/or triptans to examine the efficacy of Rizatriptan 10 mg RPD in this group of patients.

Timeline

Start

2008-05

Primary completion

2010-06

Completion

2010-06

Drugs

Indications